Identification of m6A Modification Regulated by Dysregulated circRNAs in Decidua of Recurrent Pregnancy Loss.

ceRNA network circRNAs decidua m6A modification recurrent pregnancy loss serum

Journal

Current issues in molecular biology
ISSN: 1467-3045
Titre abrégé: Curr Issues Mol Biol
Pays: Switzerland
ID NLM: 100931761

Informations de publication

Date de publication:
31 Oct 2023
Historique:
received: 27 09 2023
revised: 19 10 2023
accepted: 24 10 2023
medline: 24 11 2023
pubmed: 24 11 2023
entrez: 24 11 2023
Statut: epublish

Résumé

N6-methyladenosine (m6A) modification is a prevalent modification of messenger ribonucleic acid (mRNA) in eukaryote cells and is closely associated with recurrent pregnancy loss (RPL). Circular RNAs (circRNAs) play critical roles in embryo implantation, trophoblast invasion and immune balance, which are important events during pregnancy. However, how m6A modification is regulated by circRNAs and the potential regulatory mechanism of circRNAs on RPL occurrence remain largely unclassified. We displayed the expression profiles of circRNAs and mRNAs in the decidua of normal pregnancies and RPL patients based on circRNA sequencing and the Gene Expression Omnibus database. A total of 936 differentially expressed circRNAs were identified, including 509 upregulated and 427 downregulated circRNAs. Differentially expressed circRNAs were enriched in immune, metabolism, signaling and other related pathways via the analysis of Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway. The competitive endogenous RNA (ceRNA) network was predicted to supply the possible role of circRNAs in RPL occurrence, and we further analyzed the profiles of nine m6A regulators (seven readers, one writer and one eraser) managed by circRNAs in this network. We also showed the expression profiles of circRNAs in the serum, trying to seek a potential biomarker to help in the diagnosis of RPL. These data imply that circRNAs are involved in pathogenesis of RPL by changing immune activities, metabolism and m6A modification in the ceRNA network. Our study might provide assistance in exploring the pathogenesis and diagnosis of RPL.

Identifiants

pubmed: 37998728
pii: cimb45110551
doi: 10.3390/cimb45110551
pmc: PMC10670759
doi:

Types de publication

Journal Article

Langues

eng

Pagination

8767-8779

Subventions

Organisme : Special Youth Project for Clinical Research in Health Industry of Shanghai Municipal Health Commission
ID : 20224Y0005
Organisme : National Nature Science Foundation of China
ID : 82201852
Organisme : Nature Science Foundation of Shanghai
ID : 21ZR1410500

Références

J Cell Physiol. 2021 Oct;236(10):7223-7241
pubmed: 33876837
Cell Res. 2015 Aug;25(8):981-4
pubmed: 26138677
Mol Cell. 2023 Feb 2;83(3):428-441
pubmed: 36736310
PLoS One. 2021 May 18;16(5):e0251233
pubmed: 34003838
Am J Reprod Immunol. 2022 Jan;87(1):e13507
pubmed: 34724268
Gene. 2014 Nov 1;551(1):1-14
pubmed: 25168894
J Pathol. 2011 Dec;225(4):554-64
pubmed: 22025212
Cancer Gene Ther. 2023 Jan;30(1):163-171
pubmed: 36127411
FASEB J. 2023 Mar;37(3):e22802
pubmed: 36786696
Int J Mol Sci. 2022 Apr 20;23(9):
pubmed: 35562943
Genes Dis. 2019 Jun 25;7(3):414-423
pubmed: 32884996
BJOG. 2016 Dec;123(13):2119
pubmed: 26923099
Am J Reprod Immunol. 2022 Jan;87(1):e13505
pubmed: 34687115
Genes Dis. 2022 Jun 10;10(3):650-653
pubmed: 37396548
Biochem Genet. 2022 Feb;60(1):267-285
pubmed: 34184135
Cell Res. 2017 Mar;27(3):444-447
pubmed: 28106076
J Endocrinol. 2019 Mar 1;240(3):417-429
pubmed: 30667362
Front Immunol. 2020 Aug 18;11:2025
pubmed: 32973809
Nat Rev Dis Primers. 2020 Dec 10;6(1):98
pubmed: 33303732
Exp Biol Med (Maywood). 2018 Oct;243(14):1109-1117
pubmed: 30458645
Int J Biol Sci. 2022 Jan 1;18(2):599-616
pubmed: 35002512
Front Immunol. 2022 Sep 26;13:988130
pubmed: 36225914
Front Immunol. 2023 Jun 19;14:1203719
pubmed: 37404833
Front Genet. 2022 Sep 02;13:925652
pubmed: 36118846
J Reprod Immunol. 2023 Mar;156:103829
pubmed: 36805906
J Ovarian Res. 2018 Jan 17;11(1):9
pubmed: 29343298
Front Cell Dev Biol. 2022 Jun 14;10:894810
pubmed: 35774226
Clin Epigenetics. 2018 Apr 10;10:48
pubmed: 29643944
J Immunol. 2011 Dec 1;187(11):5615-26
pubmed: 22048764
Int J Mol Sci. 2023 May 31;24(11):
pubmed: 37298501
Front Immunol. 2021 Sep 17;12:717483
pubmed: 34603292
Placenta. 2015 Jun;36(6):652-60
pubmed: 25840495
Int J Mol Sci. 2022 Dec 08;23(24):
pubmed: 36555215
Am J Reprod Immunol. 2021 Nov;86(5):e13485
pubmed: 34270834
Elife. 2021 Oct 28;10:
pubmed: 34709177
Reprod Biol Endocrinol. 2023 May 24;21(1):50
pubmed: 37226177
Cell Physiol Biochem. 2018;46(6):2576-2586
pubmed: 29758559
Science. 2020 Jan 31;367(6477):580-586
pubmed: 31949099

Auteurs

Liyuan Cui (L)

Laboratory for Reproductive Immunology, Hospital of Obstetrics and Gynecology, Shanghai Medical College, Fudan University, Shanghai 200090, China.
State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, Fudan University, Shanghai 200032, China.

Minfeng Shi (M)

Reproductive Medicine Center, Changhai Hospital, Naval Medical University, Shanghai 200433, China.

Xinhang Meng (X)

Laboratory for Reproductive Immunology, Hospital of Obstetrics and Gynecology, Shanghai Medical College, Fudan University, Shanghai 200090, China.

Jinfeng Qian (J)

Laboratory for Reproductive Immunology, Hospital of Obstetrics and Gynecology, Shanghai Medical College, Fudan University, Shanghai 200090, China.

Songcun Wang (S)

Laboratory for Reproductive Immunology, Hospital of Obstetrics and Gynecology, Shanghai Medical College, Fudan University, Shanghai 200090, China.

Classifications MeSH